Although the clinical trial results may not guarantee an equally high level of real-world protection, the success indicates the vaccine could be effective enough to stop the pandemic if widely distributed.
Outbreaks and Epidemics
ScienceInsider interviews New York University epidemiologist and infectious disease expert Céline Gounder, one of 13 people President-elect Joe Biden has named to a coronavirus task force.
As COVID-19 cases in Germany top 20,000 per day and social life is restricted, most schools and daycares remain open, unlike in spring.
From City Hall to the White House, our investigation found, officials let Triumph Foods stay open as hundreds of workers got coronavirus. Four died.
Inadequate housing, lack of transportation, financial woes, discrimination, and violence have plagued these impoverished places for generations, fueling increased stresses on health.
ScienceInsider followed up with vaccine experts to address some of the confusion surrounding the vaccine.
Scientists say mutations in the virus might reduce the efficacy of COVID-19 vaccines.
A Russian institute announced its vaccine trial has had remarkable success. But the report is being met with raised eyebrows.
Scientists are becoming ever more creative in their search for ways to protect people from COVID-19.
The leftist state government of Kerala brought the number of daily new cases down to almost zero in the first few months. Much of the credit goes to K.K. Shailaja.
President-elect Joe Biden is wasting little time in moving to confront the pandemic, but the crisis could get much worse before he is able to begin to execute his plans.
It’s an “amazing feat” that a vaccine has a clear efficacy signal just 11 months after SARS-CoV-2 was identified, said one researcher. But hurdles still remain for developers Pfizer and BioNTech.
Aid organizations and governments spend billions on public health aid in developing countries. Why do so many Ebola and TB clinics still lack basic resources?
Advanced technologies for tuberculosis testing could save millions of lives, but only if they are designed to reach those who need them most: the poor in the developing world.
Students journey across the globe to report on issues that matter—from migration to global health and indigenous land rights.
Frontline health workers ignored and underpaid in $3.3 billion fight against Ebola.
View 2014 Campus Consortium symposium with journalists and professors focusing on human rights and the global fight against AIDS at Johns Hopkins Bloomberg School of Public Health.
Scientific detective timeline tracing the origins of HIV nominated for best science website.
Matter of ACT Special Mention Award for Best Film goes to 'The Abominable Crime.'
Who is looking out for journalists, especially freelancers, working in hostile environments and conflict zones?
Targeting care to poor and developing communities reduces stigma and deters development of drug-resistant strains of TB. Can a new diagnostic test be the turning point in the fight against TB?
Ebola is on the wane in West Africa but pregnant women and newborn children remain vulnerable to its effects.
Journalist goes to cover military efforts in Liberia, finds hope instead.
Micah Fink hopes film inspires engagement on difficult conversation about homophobia, especially in Jamaica.